Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand

PURPOSE: We assess the efficacy of two next-generation biologic therapies in treating experimental autoimmune uveitis. METHODS: Variable binding domains from shark immunoglobulin novel antigen receptors (VNARs) were fused with a mouse IgG2a constant domain (Fc) to generate VNAR-Fc molecules with bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepple, Kathryn L., Wilson, Leslie, Van Gelder, Russell N., Kovaleva, Marina, Ubah, Obinna C., Steven, John, Barelle, Caroline J., Porter, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753974/
https://www.ncbi.nlm.nih.gov/pubmed/31588375
http://dx.doi.org/10.1167/tvst.8.5.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753974/
https://www.ncbi.nlm.nih.gov/pubmed/31588375
http://dx.doi.org/10.1167/tvst.8.5.11

Ejemplares similares